|
多肽合成
热销产品 
目录多肽
|
尿皮素
Peptide Name |
CAT# |
Peptide Sequence |
(Tyr0)-Urocortin, rat |
1970-2-1 |
Tyr-Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 |
Urocortin II, human |
1970-2-2 |
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH2 |
Urocortin II, human |
1970-2-3 |
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH2 |
Urocortin II, mouse |
1970-2-4 |
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2 |
Urocortin III, human |
1970-2-5 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 |
Urocortin III, human |
1970-2-6 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 |
Urocortin III, mouse |
1970-2-7 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2 |
Urocortin III, mouse |
1970-2-8 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2 |
Urocortin III, mouse, free acid |
1970-2-9 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile |
Urocortin III, mouse, free acid |
1970-2-10 |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile |
Urocortin, human |
1970-2-11 |
Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 |
Urocortin, rat |
1970-2-12 |
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 |
|
RGD环肽合成
糖肽的合成:O-glycosylated peptide; N-glycosylated peptide; O or N-Linked di- or multi-glycopeptide
KLH, BSA, Ovalbumin等蛋白偶联
荧光标记技术:5'-Fam; 6'-Fam; Rodamine; Cy3; Cy5; BODIPY FL; AMC; AFC; FITC; Dansyl等
Fmoc-Lys(Me,Boc)-OH, Fmoc-Lys(Me)2-OH and Fmoc-Lys(Me)3-OH及甲基化多肽的合成
各种N端和C端的标记技术技术:Acetylation (N-Terminal), Acetylation (Lys), Formylation (N-Terminal), Fatty acid (N-Terminal), Myristic acid (N-Terminal), Palmytolyl (N-Terminal), Cys(Acm), Cys(tBu), Benzyloxycarbonylation (CBZ), Amidation (C-Terminal), p-Nitroanilide (pNA, C-Terminal), AMC ( C-Terminal), AFC ( C-Terminal), Succinylation (Suc, N-Terminal)
根据客户需求进行的小分子修饰技术
-
上海强耀生物总经理与武汉光谷生物城产业发展处李博士洽谈投资合作事宜,达成初步意向。强耀生物将要投资武汉光谷生物城,在武汉建立新的多肽生产基地,本项目预计在2011年底建成,届时将成为华中地区最大的多肽生产和研发基地。 2010年3月16日
- 更多新闻...
|